In contrast, metformin, a frequently prescribed medication for type 2 diabetes mellitus, along with other biguanides, indirectly activates AMPK by inhibiting the mitochondrial respiratory chain complex I, leading to an increase in AMP levels. The gene discussed is PRKAA1; the disease is diabetes mellitus.